CHELSEA OBSTETRICS LIMITEDActive

Company number 08217194Private limited companyIncorporated 2012

Key figures

£1,392,744+4.4%
Net assets 2024/25
+9.1%
Average annual growth 2020/21–2024/25
0500 k1 m1.5 m2020/212021/222022/232023/242024/25

Like most small UK companies, CHELSEA OBSTETRICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand83,49820,14436,9362,73640,422
Total assets1,191,8871,182,8801,336,8991,453,1261,547,748
Total liabilities210,594114,849142,811119,592155,004
Net assets / total equity981,2931,068,0311,194,0881,333,5341,392,744
Average number of employees11220

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CHELSEA OBSTETRICS LIMITED

Company

CHELSEA OBSTETRICS LIMITED is a private limited company registered with Companies House under company number 08217194. It was incorporated on 17 Sep 2012. Its status is active. The registered office is in Pinner (HA5). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Net assets were £1,392,744, up 4.4% on the previous year. Cash at bank and in hand was £40,422. Total assets were £1,547,748 and total liabilities £155,004. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 31 Jul 2027.